I recommend you all send an email to the fda.. dr
Post# of 148158
druginfo@fda.hhs.gov and ask them specifically now that the bar has been changed for EUA ( blood plasma no double blind placebo trial) how will they look at drugs like Leronlimab that are proven safe, effective and are in late stage double blind trials ? ..
I also recommend for anyone on this board from the state of Washington, you email your senators and house representation and start barking in their ear about how a small drug company in their state may be the answer and what are they doing about it !